Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status.

British journal of cancer - 30 Mar 2010

Evans D G R, Moran A, Hartley R, Dawson J, Bulman B, Knox F, Howell A, Lalloo F

Abstract excerpt

BACKGROUND: There are relatively few articles addressing long-term follow-up in women with breast cancer at very young ages. METHODS: We have updated and extended our population-based analysis of breast cancer diagnosed at the age < or =30 years in North-west England to include an extra 15 patients with mutation testing in BRCA1, BRCA2 and TP53, with 115 of 288 consecutive cases being tested. Kaplan-Meier curves...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to England

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Follow-Up Studies

Share to Genes, BRCA1

Share to Genes, BRCA2

Share to Genes, p53

Share to Survival Analysis

Share to Survivors

Source

Open in PubMed Open full text

Identifiers

PMID: 20234365
DOI: 10.1038/sj.bjc.6605606
PMCID: PMC2853095

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term outcomes of breast cancer in women aged 30 years or younger, based on family history, pathology and BRCA1/BRCA2/TP53 status.PMID 20234365Read ↗

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study.Semantic proximity Read ↗

Comparison of Long-Term Oncological Results in Young Women with Breast Cancer between BRCA-Mutation Carriers Versus Non-Carriers: How Tumor and Genetic Risk Factors Influence the Clinical PrognosisSemantic proximity Read ↗

BRCA1, BRCA2 and TP53 mutations in very early-onset breast cancer with associated risks to relatives.Semantic proximity Read ↗

Results from London Regional Clinical Genetics services over a 5-year period on germline TP53 testing in women diagnosed with breast cancer at <30 years.Semantic proximity Read ↗

BRCA detection rate in an Italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: when biology overcomes genealogy.Semantic proximity Read ↗

Prediction of pathogenic mutations in patients with early-onset breast cancer by family history.Semantic proximity Read ↗

Breast cancer incidence and early diagnosis in a family history risk and prevention clinic: 33-year experience in 14,311 women.Semantic proximity Read ↗

Risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a 30-year semi-prospective analysis.Semantic proximity Read ↗

Breast cancer risk after age 60 among BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Effect of BRCA1/2 mutation on short-term and long-term breast cancer survival: a systematic review and meta-analysis.Semantic proximity Read ↗

Prevalence of targetable genomic alterations in young women with advanced breast cancer: a cross-sectional study.Semantic proximity Read ↗

Routine TP53 testing for breast cancer under age 30: ready for prime time?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.